{"transactions":[{"id":730889,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."}],"balance_after":827701,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730888,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."}],"balance_after":830701,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730887,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."}],"balance_after":835701,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730886,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-18","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":6.35,"value":19050.0,"ownership":{"direct":true},"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730885,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0.75,"value":2250.0,"ownership":{"direct":true},"balance_after":703000,"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730884,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-10","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":6.24,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.20 to $6.30. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730883,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0.75,"value":3750.0,"ownership":{"direct":true},"balance_after":705000,"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730882,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":6.15,"value":18450.0,"ownership":{"direct":true},"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":730881,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:02:41.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0.75,"value":2250.0,"ownership":{"direct":true},"balance_after":703000,"source":{"system":"sec-edgar","filing":"0001140361-26-025950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025950/form4.xml","form_type":"4"}},{"id":738263,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:01:12.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."}],"balance_after":838701,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0001140361-26-025208","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025208/form4.xml","form_type":"4"}},{"id":738262,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:01:12.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":6.17,"value":17276.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.16 to $6.18. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-025208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025208/form4.xml","form_type":"4"}},{"id":738261,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T20:01:12.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":2800,"price":0.75,"value":2100.0,"ownership":{"direct":true},"balance_after":702800,"source":{"system":"sec-edgar","filing":"0001140361-26-025208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126025208/form4.xml","form_type":"4"}},{"id":742098,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:01:15.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":6418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":841501,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":6418},"source":{"system":"sec-edgar","filing":"0001140361-26-024929","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024929/form4.xml","form_type":"4"}},{"id":742097,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:01:15.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":847919,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001140361-26-024929","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024929/form4.xml","form_type":"4"}},{"id":742096,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:01:15.000Z","date":"2026-06-10","kind":"sale","planned":false,"acquired":false,"shares":6418,"price":6.21,"value":39855.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.11 to $6.30. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024929/form4.xml","form_type":"4"}},{"id":742095,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:01:15.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":6418,"price":0.75,"value":4813.5,"ownership":{"direct":true},"balance_after":706418,"source":{"system":"sec-edgar","filing":"0001140361-26-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024929/form4.xml","form_type":"4"}},{"id":742094,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:01:15.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":14500,"price":6.14,"value":89030.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.0597 to $6.19. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024929/form4.xml","form_type":"4"}},{"id":742093,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:01:15.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":14500,"price":0.75,"value":10875.0,"ownership":{"direct":true},"balance_after":714500,"source":{"system":"sec-edgar","filing":"0001140361-26-024929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024929/form4.xml","form_type":"4"}},{"id":746668,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:01:20.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":15401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":862419,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":15401},"source":{"system":"sec-edgar","filing":"0001140361-26-024449","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024449/form4.xml","form_type":"4"}},{"id":746667,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:01:20.000Z","date":"2026-06-04","kind":"exercise","planned":false,"acquired":false,"shares":19575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":877820,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":19575},"source":{"system":"sec-edgar","filing":"0001140361-26-024449","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024449/form4.xml","form_type":"4"}},{"id":746666,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:01:20.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":15401,"price":6.4,"value":98566.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.15 to $6.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-024449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024449/form4.xml","form_type":"4"}},{"id":746665,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:01:20.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":15401,"price":0.75,"value":11550.75,"ownership":{"direct":true},"balance_after":715401,"source":{"system":"sec-edgar","filing":"0001140361-26-024449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024449/form4.xml","form_type":"4"}},{"id":746664,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:01:20.000Z","date":"2026-06-04","kind":"sale","planned":false,"acquired":false,"shares":19575,"price":6.13,"value":119994.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.05 to $6.30. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-024449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024449/form4.xml","form_type":"4"}},{"id":746663,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-08T20:01:20.000Z","date":"2026-06-04","kind":"exercise","planned":false,"acquired":true,"shares":19575,"price":0.75,"value":14681.25,"ownership":{"direct":true},"balance_after":719575,"source":{"system":"sec-edgar","filing":"0001140361-26-024449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126024449/form4.xml","form_type":"4"}},{"id":762429,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T20:01:25.000Z","date":"2026-05-26","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."}],"balance_after":897395,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001140361-26-022980","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022980/form4.xml","form_type":"4"}},{"id":762428,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T20:01:25.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."}],"balance_after":901395,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001140361-26-022980","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022980/form4.xml","form_type":"4"}},{"id":762427,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:01:25.000Z","date":"2026-05-26","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":6.1001,"value":24400.4,"ownership":{"direct":true},"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-022980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022980/form4.xml","form_type":"4"}},{"id":762426,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:01:25.000Z","date":"2026-05-26","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0.75,"value":3000.0,"ownership":{"direct":true},"balance_after":704000,"source":{"system":"sec-edgar","filing":"0001140361-26-022980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022980/form4.xml","form_type":"4"}},{"id":762425,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:01:25.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":3500,"price":6.08,"value":21280.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.04 to $6.1051. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-022980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022980/form4.xml","form_type":"4"}},{"id":762424,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:01:25.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":3500,"price":0.75,"value":2625.0,"ownership":{"direct":true},"balance_after":703500,"source":{"system":"sec-edgar","filing":"0001140361-26-022980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022980/form4.xml","form_type":"4"}},{"id":766511,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T22:19:30.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":12820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":904895,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":12820},"source":{"system":"sec-edgar","filing":"0001140361-26-022642","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022642/form4.xml","form_type":"4"}},{"id":766510,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T22:19:30.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":9400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":917715,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":9400},"source":{"system":"sec-edgar","filing":"0001140361-26-022642","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022642/form4.xml","form_type":"4"}},{"id":766509,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T22:19:30.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":12820,"price":6.15,"value":78843.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.05 to $6.22. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-022642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022642/form4.xml","form_type":"4"}},{"id":766508,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T22:19:30.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":12820,"price":0.75,"value":9615.0,"ownership":{"direct":true},"balance_after":712820,"source":{"system":"sec-edgar","filing":"0001140361-26-022642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022642/form4.xml","form_type":"4"}},{"id":766507,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T22:19:30.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":9400,"price":6.15,"value":57810.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.0908 to $6.2935. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-022642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022642/form4.xml","form_type":"4"}},{"id":766506,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T22:19:30.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":9400,"price":0.75,"value":7050.0,"ownership":{"direct":true},"balance_after":709400,"source":{"system":"sec-edgar","filing":"0001140361-26-022642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022642/form4.xml","form_type":"4"}},{"id":770403,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-20T20:01:24.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":9120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":927115,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":9120},"source":{"system":"sec-edgar","filing":"0001140361-26-022235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022235/form4.xml","form_type":"4"}},{"id":770402,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-20T20:01:24.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":936235,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001140361-26-022235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022235/form4.xml","form_type":"4"}},{"id":770401,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:01:24.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":9120,"price":6.37,"value":58094.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.3002 to $6.4119. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-022235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022235/form4.xml","form_type":"4"}},{"id":770400,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:01:24.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":9120,"price":0.75,"value":6840.0,"ownership":{"direct":true},"balance_after":709120,"source":{"system":"sec-edgar","filing":"0001140361-26-022235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022235/form4.xml","form_type":"4"}},{"id":770399,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:01:24.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":200,"price":6.62,"value":1324.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.6102 to $6.6215. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-022235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022235/form4.xml","form_type":"4"}},{"id":770398,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:01:24.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":0.75,"value":150.0,"ownership":{"direct":true},"balance_after":700200,"source":{"system":"sec-edgar","filing":"0001140361-26-022235","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126022235/form4.xml","form_type":"4"}},{"id":775557,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:01:22.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":936435,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":13100},"source":{"system":"sec-edgar","filing":"0001140361-26-021889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126021889/form4.xml","form_type":"4"}},{"id":775556,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:01:22.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":15580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are vested in full."}],"balance_after":949535,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":15580},"source":{"system":"sec-edgar","filing":"0001140361-26-021889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126021889/form4.xml","form_type":"4"}},{"id":775555,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:01:22.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":13100,"price":6.65,"value":87115.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.58 to $6.85. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-021889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126021889/form4.xml","form_type":"4"}},{"id":775554,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:01:22.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":13100,"price":0.75,"value":9825.0,"ownership":{"direct":true},"balance_after":713100,"source":{"system":"sec-edgar","filing":"0001140361-26-021889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126021889/form4.xml","form_type":"4"}},{"id":775553,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:01:22.000Z","date":"2026-05-14","kind":"sale","planned":false,"acquired":false,"shares":15580,"price":6.91,"value":107657.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.8326 to $7.28. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-26-021889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126021889/form4.xml","form_type":"4"}},{"id":775552,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:01:22.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":15580,"price":0.75,"value":11685.0,"ownership":{"direct":true},"balance_after":715580,"source":{"system":"sec-edgar","filing":"0001140361-26-021889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126021889/form4.xml","form_type":"4"}},{"id":1149604,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-15T00:21:22.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":965115,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-25-019053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125019053/form4.xml","form_type":"4"}},{"id":1149603,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-05-15T00:21:22.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.75,"value":37500.0,"ownership":{"direct":true},"balance_after":700000,"source":{"system":"sec-edgar","filing":"0001140361-25-019053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125019053/form4.xml","form_type":"4"}},{"id":1165862,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-25T20:01:13.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":1015115,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-015712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125015712/form4.xml","form_type":"4"}},{"id":1165861,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-25T20:01:13.000Z","date":"2025-03-26","kind":"exercise","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":1165115,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-25-015712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125015712/form4.xml","form_type":"4"}},{"id":1165860,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-25T20:01:13.000Z","date":"2025-03-24","kind":"exercise","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":1365115,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-25-015712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125015712/form4.xml","form_type":"4"}},{"id":1165859,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:01:13.000Z","date":"2025-03-27","kind":"exercise","planned":false,"acquired":true,"shares":150000,"price":0.75,"value":112500.0,"ownership":{"direct":true},"balance_after":650000,"source":{"system":"sec-edgar","filing":"0001140361-25-015712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125015712/form4.xml","form_type":"4"}},{"id":1165858,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:01:13.000Z","date":"2025-03-26","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":0.75,"value":150000.0,"ownership":{"direct":true},"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001140361-25-015712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125015712/form4.xml","form_type":"4"}},{"id":1165857,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:01:13.000Z","date":"2025-03-24","kind":"exercise","planned":false,"acquired":true,"shares":300000,"price":0.75,"value":225000.0,"ownership":{"direct":true},"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001140361-25-015712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125015712/form4.xml","form_type":"4"}},{"id":1213000,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-12T00:00:30.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 300,000 shares of the Issuer's common stock and will vest in 48 equal monthly installments through March 7, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":10.32,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-25-008167","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125008167/form4.xml","form_type":"4"}},{"id":1731643,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":36464,"kind":"person","name":"Ye Weiguo","position":1,"cik":"0001985496","reported_name":"Ye Weiguo","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-23T00:49:12.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":1665115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China (\"Beijing Continent\"), terminated its 2021 Stock Incentive Plan (the \"2021 Plan\") and each option (a \"BC Option\") to purchase common shares of Beijing Continent outstanding under the 2021 Plan was terminated and replaced with options granted pursuant to a sub-plan for Chinese participants under the Issuer's 2023 Omnibus Incentive Plan that are substantially similar in all material respects to the BC Options previously outstanding under the 2021 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China (\"Beijing Continent\"), terminated its 2021 Stock Incentive Plan (the \"2021 Plan\") and each option (a \"BC Option\") to purchase common shares of Beijing Continent outstanding under the 2021 Plan was terminated and replaced with options granted pursuant to a sub-plan for Chinese participants under the Issuer's 2023 Omnibus Incentive Plan that are substantially similar in all material respects to the BC Options previously outstanding under the 2021 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are vested in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China (\"Beijing Continent\"), terminated its 2021 Stock Incentive Plan (the \"2021 Plan\") and each option (a \"BC Option\") to purchase common shares of Beijing Continent outstanding under the 2021 Plan was terminated and replaced with options granted pursuant to a sub-plan for Chinese participants under the Issuer's 2023 Omnibus Incentive Plan that are substantially similar in all material respects to the BC Options previously outstanding under the 2021 Plan."}],"balance_after":1665115,"derivative":{"exercise_price":0.75,"expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":1665115},"source":{"system":"sec-edgar","filing":"0001140361-23-054520","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123054520/form4.xml","form_type":"4"}}]}